Dr. Lucie Ide, CEO of Rimidi Diabetes, Named to Southeastern Board of the American Diabetes Association


ATLANTA, GA– July 14, 2016– Dr. Lucie Ide, CEO of Atlanta’s Rimidi Diabetes, has recently been named to the Georgia Community Leadership Board of the American Diabetes Association.

Dr. Ide, MD, PhD, is a physician scientist who trained at Emory University and completed her internship at University of Pittsburgh Medical Center before founding Rimidi.

Rimidi Diabetes is a digital health company whose diabetes management platform, Diabetes+Me, empowers patients and providers to identify and close diabetes management gaps, meet patient glucose targets and create a more efficient care cycle.

“I am honored to be selected to the Georgia board of the American Diabetes Association,” said Dr. Ide. “This will allow me to lend my expertise in digital health to the association and become more involved with the local diabetes community. This is especially relevant as the national ADA recently announced a partnership with IBM Watson and a focus on the use of technology to improve the lives of individuals living with diabetes.”

“The American Diabetes Association is thrilled to have Dr. Ide join our local Community Leadership Board (CLB),” said Tiffany Kirkland, American Diabetes Association, Area Executive Director. “She will bring an incredible skillset in healthcare technology to our organization. The Georgia CLB supports the American Diabetes Association in achieving its strategic objectives in alignment with the mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.. The American Diabetes Association is the only organization pursuing treatments, prevention and cures for all types of diabetes and fighting for the rights of all people affected by diabetes.”

Rimidi is a TAG Top 10 Innovative Technology Company, and recently won the top prize in the inaugural Healthways Innovation Living Lab Pitch Fest ‘16. In addition, the company is a member of The Healthbox Florida Studio in Partnership with GuideWell Innovation, an accelerator program, and has presented its technology to Congress as a member of the App Association.

About Rimidi
Rimidi is an Atlanta-based, woman-led digital health company bringing to market data analytics and disease management solutions. Its flagship product, Diabetes+Me™, is a software solution focused on empowering quality diabetes care for healthcare organizations and providers. Rimidi has received funding from SOURCE, a partnership between the Hitachi Foundation, Investor’s Circle and Village Capital. The company also received funding from the JumpFund, whose mission is to invest women’s capital in female-led companies with growth potential. For more information, visit www.rimidi.com.

About the American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association’s mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. To connect with the local Georgia office, please call 404-320-7100 of connect via social media Facebook (American Diabetes Association – Georgia), Twitter (@AmDiabetesATL) and Instagram (@ada_atl). For more information on the national organization, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)

Comments are closed